-
1 Comment
ResMed Inc is currently in a long term uptrend where the price is trading 23.6% above its 200 day moving average.
From a valuation standpoint, the stock is 96.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.2.
ResMed Inc's total revenue rose by 8.7% to $800M since the same quarter in the previous year.
Its net income has increased by 11.8% to $180M since the same quarter in the previous year.
Finally, its free cash flow grew by 680.6% to $135M since the same quarter in the previous year.
Based on the above factors, ResMed Inc gets an overall score of 5/5.
ISIN | AU000000RMD6 |
---|---|
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CurrencyCode | AUD |
Exchange | AU |
PE Ratio | 40.19 |
---|---|
Dividend Yield | 0.8% |
Market Cap | 49B |
Beta | 0.47 |
Target Price | 36.14 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RMD.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024